These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 9079789
41. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M. J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210 [Abstract] [Full Text] [Related]
42. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain. Iben LG, Mahle CD, Yocca FD. Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298 [Abstract] [Full Text] [Related]
43. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN. Uphouse L, Caldarola-Pastuszka M, Maswood S, Andrade M, Moore N. Brain Res; 1994 Feb 21; 637(1-2):173-80. PubMed ID: 8180795 [Abstract] [Full Text] [Related]
44. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine. Zhang Z, Rickard JF, Body S, Asgari K, Bradshaw CM, Szabadi E. Psychopharmacology (Berl); 2005 Sep 21; 181(2):381-91. PubMed ID: 15830225 [Abstract] [Full Text] [Related]
46. Working memory deficits induced by intrahippocampal administration of 8-OH-DPAT, a 5-HT1A receptor agonist, in the rat. Ohno M, Yamamoto T, Watanabe S. Eur J Pharmacol; 1993 Mar 30; 234(1):29-34. PubMed ID: 8472759 [Abstract] [Full Text] [Related]
47. Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus. Hogg S, Andrews N, File SE. Neuropharmacology; 1994 Mar 30; 33(3-4):343-8. PubMed ID: 7984272 [Abstract] [Full Text] [Related]
52. Administration of 8-OH-DPAT into the midbrain raphe nuclei: effects on medial hypothalamic NE-induced feeding. Currie PJ, Fletcher PJ, Coscina DV. Am J Physiol; 1994 May 30; 266(5 Pt 2):R1645-51. PubMed ID: 8203645 [Abstract] [Full Text] [Related]
53. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Casanovas JM, Lésourd M, Artigas F. Br J Pharmacol; 1997 Oct 30; 122(4):733-41. PubMed ID: 9375971 [Abstract] [Full Text] [Related]
57. Hippocampal asymmetry in the behavioral responses to the 5-HT1A receptor agonist 8-OH-DPAT. Belcheva I, Belcheva S, Petkov VV, Petkov VD. Brain Res; 1994 Mar 21; 640(1-2):223-8. PubMed ID: 7911727 [Abstract] [Full Text] [Related]
58. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior. Uphouse L, Andrade M, Caldarola-Pastuszka M, Maswood S. Pharmacol Biochem Behav; 1994 Mar 21; 47(3):467-70. PubMed ID: 8208763 [Abstract] [Full Text] [Related]